Grapefruit’s bitter taste holds a sweet promise for diabetes therapy
A team of researchers from the Hebrew University of Jerusalem and Massachusetts General Hospital report that naringenin activates a family of small proteins, called nuclear receptors, causing the liver to break down fatty acids.